5
1
9780393704211
$27.5
Current price is , Original price is $27.5. You
Psychotropic Drugs and Women: Fast Facts available in Paperback
Psychotropic Drugs and Women: Fast Facts
by Victoria Hendrick M.D., Michael Gitlin M.D.
Victoria Hendrick M.D.
- ISBN-10:
- 0393704211
- ISBN-13:
- 9780393704211
- Pub. Date:
- 04/17/2004
- Publisher:
- Norton, W. W. & Company, Inc.
- ISBN-10:
- 0393704211
- ISBN-13:
- 9780393704211
- Pub. Date:
- 04/17/2004
- Publisher:
- Norton, W. W. & Company, Inc.
Psychotropic Drugs and Women: Fast Facts
by Victoria Hendrick M.D., Michael Gitlin M.D.
Victoria Hendrick M.D.
Paperback
Buy New
$27.50Buy Used
$19.25
$27.50
-
-
SHIP THIS ITEM
Temporarily Out of Stock Online
Please check back later for updated availability.
-
27.5
In Stock
Overview
At a time when the use of psychotropic drugs is on the rise and the medical understanding of female physiology is becoming increasingly complex, the specific treatment needs of women seeking psychiatric or psychological care demand special attention. Designed as a practical day-to-day clinical practice guide, Psychotropic Drugs and Women provides information for the treatment of psychiatric disorders across the reproductive lives of women. Whereas potential risks of medication exposure during pregnancy had once been the key consideration when prescribing psychotropic drugs, research has shown that throughout a woman's life there are other no-less-important risks and reactions unique to the female physiology. Inside this book, readers will find extended discussions of the medication of depressive disorders, bipolar disorders, anxiety disorders, schizophrenia, and eating disorders. Key drug classes such as antidepressants, antipsychotics, anxiolytics, mood stabilizers, and stimulants are discussed throughout as they apply to these various disorders. There are also wide-ranging chapters addressing the general implications of female physiology on psychopharmacology as well as the female reproductive system and central nervous system. Bibliographies corresponding to each chapter point clinicians in the right direction when further research is required. As with other volumes in Norton's 'Fast Facts' series, Psychotropic Drugs and Women: Fast Facts presents all the critical information pertaining to prescription, cross-indication, and side effects, often in easy-to-read tables and charts. This handy guide is essential reading for all physicians and mental health professionals.
Product Details
ISBN-13: | 9780393704211 |
---|---|
Publisher: | Norton, W. W. & Company, Inc. |
Publication date: | 04/17/2004 |
Series: | Fast Facts |
Edition description: | New Edition |
Pages: | 256 |
Product dimensions: | 5.50(w) x 8.40(h) x 0.70(d) |
About the Author
Victoria Hendrick, M.D., is Associate Professor of Psychiatry at the UCLA Neuropsychiatric Hospital. Her research focuses on the treatment of psychiatric disorders during pregnancy and nursing and she has published extensively on topics related to perinatal psychiatry and women's mental health.
Michael Gitlin, M.D., is Professor of Clinical Psychiatry and Director of the Adult Division, UCLA Department of Psychiatry, and Director of the Mood Disorders Clinic at the UCLA Neuropsychiatric Hospital.
Michael Gitlin, M.D., is Professor of Clinical Psychiatry and Director of the Adult Division, UCLA Department of Psychiatry, and Director of the Mood Disorders Clinic at the UCLA Neuropsychiatric Hospital.
Table of Contents
Abbreviations | xi | |
Preface | xiii | |
Acknowledgments | xv | |
1. | General Considerations in the Psychopharmacological Treatment of Women | 3 |
Introduction | 3 | |
The Use of Psychiatric Medications for Women of All Ages | 6 | |
The Use of Psychiatric Medications in Women of Reproductive Age | 7 | |
General Principles for Use of Psychotropic Medications During Pregnancy | 9 | |
General Principles for Use of Psychotropic Medications During Breast-Feeding | 14 | |
The Use of Psychiatric Medications for Peri- and Postmenopausal Women | 17 | |
The Use of Psychiatric Medications for Elderly Women | 18 | |
2. | Gender Differences in Psychopharmacology | 21 |
Introduction | 21 | |
Gender Differences in Pharmacokinetics of Medications | 22 | |
Gender Differences in Cytochrome P450 System | 23 | |
Effect of Menstrual Cycle on Drug Metabolism | 24 | |
Effect of Pregnancy on Drug Metabolism | 24 | |
Effect of Menopausal Status on Drug Metabolism | 25 | |
Drug Interactions | 25 | |
3. | Depressive Disorders | 31 |
Introduction | 31 | |
Antidepressants | 35 | |
Phases of Treatment | 48 | |
Treatment Considerations for Women of Reproductive Age | 49 | |
Treatment of Depression During Pregnancy | 50 | |
Pharmacological Treatment of Postpartum Depression | 58 | |
Use of Antidepressants During Breast-Feeding | 59 | |
Treatment Considerations for Peri- and Postmenopausal Women | 62 | |
Treatment Considerations for Elderly Women | 63 | |
Treatment-Resistant Depression | 63 | |
4. | Bipolar Disorder | 71 |
Introduction | 71 | |
Mood Stabilizers/Antimanic Agents | 73 | |
Phases of Treatment | 90 | |
Treatment Considerations for Women of Reproductive-Age | 92 | |
Treatment of Bipolar Disorder During Pregnancy | 94 | |
Treatment of Bipolar Disorder Following Delivery | 100 | |
Use of Mood Stabilizers During Breast-Feeding | 101 | |
Treatment Considerations for Peri- and Postmenopausal Women | 104 | |
Treatment Considerations for Elderly Women | 104 | |
Bipolar Depression | 105 | |
5. | Anxiety Disorders and Insomnia | 107 |
Introduction | 107 | |
Pharmacological Treatment of Anxiety Disorders | 109 | |
Treatment Considerations for Women of Reproductive Age | 122 | |
Treatment of Anxiety Disorders During Pregnancy | 123 | |
Treatment of Anxiety Disorders During Breast-Feeding | 125 | |
Treatment Considerations for Peri- and Postmenopausal Women | 126 | |
Treatment Considerations for Elderly Women | 126 | |
Treatment of Insomnia | 126 | |
6. | Schizophrenia | 131 |
Introduction | 131 | |
Antiposychotic Agents | 133 | |
Phases of Treatment | 147 | |
Treatment Considerations for Women of Reproductive Age | 148 | |
Treatment of Schizophrenia During Pregnancy | 149 | |
Treatment of Schizophrenia During Breast-Feeding | 153 | |
Treatment Considerations for Peri- and Postmenopausal Women | 154 | |
Treatment Considerations for Elderly Women | 155 | |
Strategies for Treatment Resistance | 155 | |
7. | Premenstrual Dysphoric Disorder | 157 |
Introduction | 157 | |
Evaluation of Women Presenting with Premenstrual Dysphoric Disorder | 158 | |
Treatments for Premenstrual Dysphoric Disorder | 160 | |
8. | Eating Disorders | 167 |
Introduction | 167 | |
Treatment of Anorexia and Bulimia Nervosa | 169 | |
Pharmacological Treatments for Bulimia Nervosa and Binge-Eating Disorder | 170 | |
Pharmacological Treatments for Anorexia Nervosa | 172 | |
Treatment of Eating Disorders During Pregnancy | 173 | |
Treatment of Eating Disorders Following Delivery | 174 | |
9. | Female Reproductive Hormones and the Central Nervous System | 177 |
Review of Female Endocrinology | 177 | |
Hormone Supplementation | 180 | |
Hormones and Mood | 182 | |
Appendix 1. | Drug Identification by Generic Name | 187 |
Appendix 2. | Drug Identification by Brand Name | 191 |
Bibliography | 195 | |
Index | 219 |
From the B&N Reads Blog
Page 1 of